483 GlaxoSmithKline dba Human Genome Sciences Apr 2013

483 GlaxoSmithKline dba Human Genome Sciences Apr 2013

Bo Chi FDA, Donald Obenhuber FDA, Nebil Oumer FDA, Zhihao Qiu FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline dba Human Genome Sciences - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 26 Apr 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Apr 2013
  • Location: Rockville, United States
  • FEI: 3003782237
Add To Cart